Suppr超能文献

疫苗实施期间的 COVID-19 退出策略:在社交距离和群体免疫之间取得平衡。

COVID-19 exit strategy during vaccine implementation: a balance between social distancing and herd immunity.

机构信息

Population Medicine Department, College of Medicine, QU Health, Qatar University, Doha, Qatar.

Basic Medical Sciences Department, College of Medicine, QU Health, Qatar University, Doha, Qatar.

出版信息

Arch Virol. 2022 Sep;167(9):1773-1783. doi: 10.1007/s00705-022-05495-7. Epub 2022 Jun 20.

Abstract

Currently, health authorities around the world are struggling to limit the spread of COVID-19. Since the beginning of the pandemic, social distancing has been the most important strategy used by most countries to control disease spread by flattening and elongating the epidemic curve. Another strategy, herd immunity, was also applied by some countries through relaxed control measures that allow the free spread of natural infection to build up solid immunity within the population. In 2021, COVID-19 vaccination was introduced with tremendous effort as a promising strategy for limiting the spread of disease. Therefore, in this review, we present the current knowledge about social distancing, herd immunity strategies, and aspects of their implementation to control the COVID-19 pandemic in the presence of the newly developed vaccines. Finally, we suggest a short-term option for controlling the pandemic during vaccine application.

摘要

目前,全球卫生当局正在努力限制 COVID-19 的传播。自大流行开始以来,社交距离一直是大多数国家用来控制疾病传播的最重要策略,通过拉平和延长疫情曲线来控制疾病传播。另一种策略,群体免疫,也被一些国家通过放宽控制措施来应用,这些措施允许自然感染自由传播,以在人群中建立坚实的免疫力。2021 年,COVID-19 疫苗接种作为一种有希望的疾病传播限制策略被大力推出。因此,在本综述中,我们介绍了关于社交距离、群体免疫策略的最新知识,以及在新开发疫苗的情况下实施这些策略以控制 COVID-19 大流行的相关方面。最后,我们提出了一种在疫苗接种期间控制大流行的短期选择。

相似文献

1
COVID-19 exit strategy during vaccine implementation: a balance between social distancing and herd immunity.
Arch Virol. 2022 Sep;167(9):1773-1783. doi: 10.1007/s00705-022-05495-7. Epub 2022 Jun 20.
2
Lockdowns and the COVID-19 pandemic: What is the endgame?
Scand J Public Health. 2021 Feb;49(1):37-40. doi: 10.1177/1403494820961293. Epub 2020 Sep 26.
3
Herd immunity: challenges and the way forward in Korea.
Epidemiol Health. 2021;43:e2021054. doi: 10.4178/epih.e2021054. Epub 2021 Aug 18.
4
The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies.
Front Immunol. 2020 Jul 21;11:1817. doi: 10.3389/fimmu.2020.01817. eCollection 2020.
5
The herd-immunity threshold must be updated for multi-vaccine strategies and multiple variants.
Sci Rep. 2021 Nov 26;11(1):22970. doi: 10.1038/s41598-021-00083-2.
6
Toward Achieving a Vaccine-Derived Herd Immunity Threshold for COVID-19 in the U.S.
Front Public Health. 2021 Jul 23;9:709369. doi: 10.3389/fpubh.2021.709369. eCollection 2021.
7
SARS-CoV-2 in Zimbabwe: milestones and challenges faced towards achieving the expected 60% herd immunity.
Pan Afr Med J. 2021 Aug 20;39:255. doi: 10.11604/pamj.2021.39.255.30331. eCollection 2021.
8
Return to normal pre-COVID-19 life is delayed by inequitable vaccine allocation and SARS-CoV-2 variants.
Epidemiol Infect. 2022 Jan 24;150:e46. doi: 10.1017/S0950268822000139.

引用本文的文献

1
COVID-19 vaccine hesitancy in Ethiopia: a latent class analysis.
BMC Public Health. 2024 Oct 21;24(1):2894. doi: 10.1186/s12889-024-20359-2.
3
Evaluation of Covid-19 anti-spike IgG antibody five months after the second Covid-19 vaccination.
GMS Hyg Infect Control. 2023 Sep 7;18:Doc20. doi: 10.3205/dgkh000446. eCollection 2023.
4
COVID-19 Among Omani Pilgrim Returnees From the Ashura Mass Gathering.
Cureus. 2023 Mar 10;15(3):e36003. doi: 10.7759/cureus.36003. eCollection 2023 Mar.

本文引用的文献

2
Community structured model for vaccine strategies to control COVID19 spread: A mathematical study.
PLoS One. 2022 Oct 27;17(10):e0258648. doi: 10.1371/journal.pone.0258648. eCollection 2022.
3
Evolution of SARS-CoV-2 virus and assessment of the effectiveness of COVID-19 vaccine.
F1000Res. 2021 Jan 18;10:28. doi: 10.12688/f1000research.28215.1. eCollection 2021.
4
COVID-19: How Omicron overtook Delta in three charts.
Nature. 2022 Mar 4. doi: 10.1038/d41586-022-00632-3.
5
Estimates of SARS-CoV-2 Omicron Variant Severity in Ontario, Canada.
JAMA. 2022 Apr 5;327(13):1286-1288. doi: 10.1001/jama.2022.2274.
6
Omicron variant (B.1.1.529) of SARS-CoV-2: Mutation, infectivity, transmission, and vaccine resistance.
World J Clin Cases. 2022 Jan 7;10(1):1-11. doi: 10.12998/wjcc.v10.i1.1.
7
Nudges against pandemics: Sweden's COVID-19 containment strategy in perspective.
Policy Soc. 2020 Jun 19;39(3):478-493. doi: 10.1080/14494035.2020.1783787. eCollection 2020 Sep.
9
Non-pharmaceutical interventions, vaccination, and the SARS-CoV-2 delta variant in England: a mathematical modelling study.
Lancet. 2021 Nov 13;398(10313):1825-1835. doi: 10.1016/S0140-6736(21)02276-5. Epub 2021 Oct 28.
10
Herd-immunity across intangible borders: Public policy responses to COVID-19 in Ireland and the UK.
Eur Policy Anal. 2020 Dec;6(2):203-225. doi: 10.1002/epa2.1096. Epub 2020 Nov 26.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验